CVS Health Rebounds as Bullish Momentum StrengthensCVS Health CorporationBATS:CVSfinvestnomicsCVS is attracting renewed buying interest after retracing. The stock has now recorded two consecutive days of accumulation following the retracement. CVS continues to trade above its well-aligned 20 and 50 moving averages, reflecting strengthening upward momentum and improving technical structure. CVS Health is a $118.62 billion market cap healthcare solutions company engaged in providing a broad range of healthcare services. The company operates through the following segments: Health Care Benefits, Health Services, Pharmacy & Consumer Wellness, and Corporate & Other. The Health Care Benefits segment operates as a healthcare benefits provider, while the Health Services segment delivers pharmacy benefit management (PBM) solutions, medical clinic services, virtual care, and in-home healthcare offerings. The Pharmacy & Consumer Wellness segment focuses on prescription dispensing through retail pharmacy and infusion operations. CVS is considered a narrow-moat company, supported by its scale, integrated healthcare platform, and extensive pharmacy network. Fundamentally, the company has delivered consistent revenue growth over the last three quarters, while EPS has improved in two of the past three quarters. Operating margin and net margin stand at 5% and 3%, respectively. Return on Equity (ROE) and Return on Invested Capital (ROIC) are 4% and 2%, respectively. The company maintains a current ratio of 0.9x and a debt-to-equity ratio of 1.0x.